Skip to main content

METHODS article

Front. Oncol.
Sec. Cancer Epidemiology and Prevention
Volume 14 - 2024 | doi: 10.3389/fonc.2024.1455281

PRIO - A Prospective Integrative Oncology Registry: Trial Protocol

Provisionally accepted
Paul G Werthmann Paul G Werthmann 1*Ann-Kathrin Lederer Ann-Kathrin Lederer 1Hannah Maja Figura Hannah Maja Figura 2Klaus Kramer Klaus Kramer 2
  • 1 University of Freiburg Medical Center, Freiburg, Germany
  • 2 Ulm University Medical Center, Ulm, Germany

The final, formatted version of the article will be published soon.

    Background: Integrative Oncology (IO) -the use of lifestyle modifications, mind-body practices and natural products in oncology -is increasingly asked for by patients. The evidence base of IO is growing and IO measures are included in national guidelines. Still, many questions about IO remain unanswered or still show a poor evidence base.Method: Data about demography, socioeconomic status, cancer disease and therapy, integrative oncology measures and patient reported outcomes will be collected in regular visits in oncological patients at the University Cancer Center Ulm, Germany. An expansion to further study centers is planned. After one year and at regular intervals, the registry will be evaluated and adapted accordingly.Discussion: The PRIO register builds a solid data base to evaluate the use of integrative oncology measures in cancer patients. It includes patient reported outcome measures to investigate quality of life and satisfaction with health services in this population. The register aims to enhance transparency in IO use and wants to inform future research in IO.The trial has been registered in the German Clinical Trials Register (DRKS) under the ID DRKS00033250 and in the studyBox of the German Cancer Association under the ID ST-U173 on 18th December 2023. The trial was approved by the ethics committee of the University Medical Center Ulm under the number 375/23 on 7th December 2023.

    Keywords: Integrative oncology, oncology registry, Demography, Quality of Life, user profile, integrative oncology consultation

    Received: 26 Jun 2024; Accepted: 21 Nov 2024.

    Copyright: © 2024 Werthmann, Lederer, Figura and Kramer. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Paul G Werthmann, University of Freiburg Medical Center, Freiburg, Germany

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.